Neopharmed
Neopharmed Gentili | Per un futuro in salute, insieme.
About
Neopharmed Gentili is an Italian pharmaceutical company specializing in vascular, cardio-metabolic, and neuropsychiatry therapeutics, expanding internationally.
Summary
Neopharmed is a Biotech company based in Milan, Italy. Its most recent funding was a Series A round in Dec 2018. Investors include Eurazeo.
Tech & App Stack
6 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Dec 2018
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Biopharmaceutical services company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...